A randomized, adaptive design, double-blind, 3-arm, parallel study assessing the pharmacokinetics and safety of AVT02, a high-concentration (100 mg/mL) Adalimumab biosimilar, in healthy adult subjects (ALVOPAD FIRST)
Wynne, Christopher, Schwabe, Christian, Lemech, Charlotte, Stroissnig, Heimo, Dias, Roshan, Sobierska, Joanna, Guenzi, Eric, Otto, Hendrik, Sattar, Abid, Kay, Richard, Haliduola, Halimu N., Berti, Fausto
Published in Expert opinion on investigational drugs (02.09.2022)
Published in Expert opinion on investigational drugs (02.09.2022)
Get full text
Journal Article
A multicenter, randomized, open-label, 2-arm parallel study to compare the pharmacokinetics, safety and tolerability of AVT02 administered subcutaneously via prefilled syringe or autoinjector in healthy adults
Wynne, Christopher, Schwabe, Christian, Stroissnig, Heimo, Dias, Roshan, Sobierska, Joanna, Guenzi, Eric, Otto, Hendrik, Sattar, Abid, Haliduola, Halimu N, Edwald, Elin, Berti, Fausto
Published in Expert opinion on biological therapy (03.08.2023)
Published in Expert opinion on biological therapy (03.08.2023)
Get full text
Journal Article
Assessing the Interchangeability of AVT02 and Humira® in Participants with Moderate‑to‑Severe Chronic Plaque Psoriasis: Pharmacokinetics, Efficacy, Safety, and Immunogenicity Results from a Multicenter, Double-Blind, Randomized, Parallel-Group Study
Feldman, Steven R., Kay, Richard, Reznichenko, Nataliya, Sobierska, Joanna, Dias, Roshan, Otto, Hendrik, Haliduola, Halimu N., Sattar, Abid, Ruffieux, Ruth, Stroissnig, Heimo, Berti, Fausto
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.07.2023)
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.07.2023)
Get full text
Journal Article
Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis: A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III Study
Feldman, Steven R., Reznichenko, Nataliya, Pulka, Grazyna, Kingo, Külli, George Galdava, Berti, Fausto, Sobierska, Joanna, Dias, Roshan, Guenzi, Eric, Hendrik Otto, Haliduola, Halimu N., Kay, Richard, Stroissnig, Heimo
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.11.2021)
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.11.2021)
Get full text
Journal Article